Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring.
Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB.
Kappos L, et al. Among authors: radue ew.
Lancet Neurol. 2007 May;6(5):431-41. doi: 10.1016/S1474-4422(07)70078-9.
Lancet Neurol. 2007.
PMID: 17434098
Review.